Pre-clinical models of infectious diseases
Ended Awarded
- Contract number
- HHSN272201700022I
- Awardee
-
KMT Hepatech Inc. UEI Q9RZP22ME9D4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $2,309 obligated
Award facts
- Opportunity
-
- NIHAI2016059 Solicitation number
- Pre-clinical models of infectious diseases Award Notice · Posted Apr 29, 2016
- Combined order value
- $2,309 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $40,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 67 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to KMT Hepatech Inc., a foreign-owned for-profit organization. The $40 million, multiple-award IDC runs from July 2017 through July 2024 and covers pre-clinical models of infectious diseases.
Under this IDC, the initial task order for $2,309 was issued in October 2017 for a base funding "kick-off" related to an Observed Bioavailability and Relative Bioavailability (OBRA) study. The place of performance is Rockville, Maryland. This IDC does not utilize any small business or socioeconomic set-asides. The contract is structured as a cost-no-fee arrangement, which is common for research and development contracts of this nature focused on providing pre-clinical infectious disease models and related services to support NIAID's mission and research priorities.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| 1700022I KMT hepatech, INC.; to A8 obra--7 base IDIQ contract kick-off base funding; biod can 8470038 $2,309 | National Institute of Allergy and Infectious Diseases (NIH) | $2,309 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Modification | $0 | |
| Other Administrative Action | $0 |
Quick answers
Who was awarded contract HHSN272201700022I?
HHSN272201700022I was awarded to KMT Hepatech Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 13, 2017.
How much is contract HHSN272201700022I worth?
Orders under HHSN272201700022I have obligated $2,309. HHSN272201700022I's own ceiling is $40,000,000.
How many orders have been placed under contract HHSN272201700022I?
1 order has been placed under HHSN272201700022I, the latest on October 19, 2017.
Who can order from contract HHSN272201700022I?
HHSN272201700022I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN272201700022I part of a contract vehicle?
Yes. HHSN272201700022I is part of NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract HHSN272201700022I competed?
The extent of competition for HHSN272201700022I was full and open competition. The government received 67 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV